Cannara Biotech (OTCMKTS:CNBTF) Shares Down 2.5% – Here’s Why

Shares of Cannara Biotech (OTCMKTS:CNBTF) traded down 2.5% on Tuesday . The stock traded as low as $1.2625 and last traded at $1.33. Approximately 13,505 shares traded hands during trading, a decline of 59% from the average session volume of 33,127 shares. The stock had previously closed at $1.3640.

Cannara Biotech Price Performance

The stock has a fifty day simple moving average of $1.22 and a 200-day simple moving average of $1.29.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.